Clinical Trials Logo

Depressive Disorder, Major clinical trials

View clinical trials related to Depressive Disorder, Major.

Filter by:

NCT ID: NCT02972632 Completed - Clinical trials for Major Depressive Disorder

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

Start date: December 22, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effectiveness of treatment with vortioxetine on participant goal achievement after a change in antidepressant medication for the treatment of major depressive disorder (MDD).

NCT ID: NCT02972398 Recruiting - Clinical trials for Major Depressive Disorders

N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders

Start date: September 2015
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of N-acetylcysteine (NAC) add-on to antidepressant medication in treating patients who do not relieve during standard antidepressant treatment for 6 weeks at least. Meanwhile, secondary outcomes will include changes in some biomarkers and on specifically local brain activity (functional Magnetic Resonance Imaging, fMRI) and white matter integrity (Diffusion Tensor Imaging, DTI). The hypothesis of this study is that NAC has positive effects on refractory major depressive disorder patients with increased inflammatory activity.

NCT ID: NCT02960763 Completed - Clinical trials for Major Depressive Disorder

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

OPTIMUM
Start date: February 24, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to assess which antidepressants work the best in older adults who have treatment-resistant depression (TRD).

NCT ID: NCT02959502 Active, not recruiting - Clinical trials for Major Depressive Disorder

Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression

Start date: October 31, 2016
Phase: N/A
Study type: Interventional

The overall goals of this project are to assess the feasibility and impact of designing and implementing an at-home intervention aimed at preventing long-term cognitive decline and improving cognition in individuals currently at-risk for developing AD.

NCT ID: NCT02959307 Completed - Depression Clinical Trials

Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)

ELATED-3
Start date: November 2016
Phase: N/A
Study type: Interventional

Transcranial Light Therapy involves non-invasive and invisible beams of light that increase energy metabolism in the brain. Transcranial light therapy has been found to promote brain metabolism which may help people with depression. The research team proposes a novel approach to treating depression by using transcranial light therapy.

NCT ID: NCT02951988 Completed - Clinical trials for Depressive Disorder, Major

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

Start date: November 13, 2016
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive treatment to ongoing anti-depressive therapy (ADT) in the prevention of relapse in participants with Major Depressive Disorder (MDD).

NCT ID: NCT02948036 Completed - Clinical trials for Major Depressive Disorder

A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Specific Aim 1: Finalize development of the closed-loop strategy in the MMT application. Specific Aim 2: Evaluate the acceptability and feasibility of the MMT application with the target population to prepare for a large-scale efficacy trial.

NCT ID: NCT02945735 Completed - Depressive Disorder Clinical Trials

Gaze Contingent Feedback in Major Depressive Disorder (MDD)

Start date: November 6, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of Major Depressive Disorder (MDD)

NCT ID: NCT02943577 Completed - Clinical trials for Depressive Disorder, Major

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Start date: November 2, 2016
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy, safety, and tolerability of rapastinel 450 milligrams (mg) compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

NCT ID: NCT02943564 Completed - Clinical trials for Depressive Disorder, Major

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

Start date: November 1, 2016
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.